Organon & Co. (OGN) News Today $15.03 -0.28 (-1.83%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Organon & Co. Q3 Earnings TranscriptNovember 16 at 7:18 AM | marketbeat.comOrganon: 7% Yield, 4x P/E, Big Upside PotentialNovember 14 at 1:04 PM | seekingalpha.comPrincipal Financial Group Inc. Sells 1,515,328 Shares of Organon & Co. (NYSE:OGN)Principal Financial Group Inc. cut its position in Organon & Co. (NYSE:OGN - Free Report) by 55.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,216,312 shares of the company's stock after selling 1,515,328 sNovember 14 at 3:20 AM | marketbeat.comOrganon: Certainly A Risky Bet, But Looks Increasingly Compelling (Upgrade)November 13, 2024 | seekingalpha.comOVERSEA CHINESE BANKING Corp Ltd Reduces Stake in Organon & Co. (NYSE:OGN)OVERSEA CHINESE BANKING Corp Ltd cut its holdings in shares of Organon & Co. (NYSE:OGN - Free Report) by 50.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 135,500 shares of the company's stock after selling 135,500 shares durNovember 13, 2024 | marketbeat.comAmalgamated Bank Has $1.54 Million Stock Holdings in Organon & Co. (NYSE:OGN)Amalgamated Bank cut its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 29.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 80,530 shares of the company's stock afterNovember 13, 2024 | marketbeat.comLos Angeles Capital Management LLC Buys 83,510 Shares of Organon & Co. (NYSE:OGN)Los Angeles Capital Management LLC boosted its holdings in shares of Organon & Co. (NYSE:OGN - Free Report) by 47.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 259,831 shares of the company's stock aNovember 12, 2024 | marketbeat.comOrganon's (NYSE:OGN) Earnings Are Weaker Than They SeemNovember 9, 2024 | finance.yahoo.comAcorn Financial Advisory Services Inc. ADV Invests $743,000 in Organon & Co. (NYSE:OGN)Acorn Financial Advisory Services Inc. ADV bought a new position in shares of Organon & Co. (NYSE:OGN - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 38,833 shares of the company's stock,November 9, 2024 | marketbeat.comVan ECK Associates Corp Has $5.29 Million Stock Holdings in Organon & Co. (NYSE:OGN)Van ECK Associates Corp boosted its position in Organon & Co. (NYSE:OGN - Free Report) by 32.2% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 276,732 shares of the company's stock after purchasing an additional 67,451 shares during the period. Van ECK AssociatNovember 9, 2024 | marketbeat.com804,262 Shares in Organon & Co. (NYSE:OGN) Bought by Philip James Wealth Mangement LLCPhilip James Wealth Mangement LLC bought a new stake in Organon & Co. (NYSE:OGN - Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 804,262 shares of the company's stock, valued at approximately $15,386,000. OrganNovember 8, 2024 | marketbeat.comEarnings Update: Organon & Co. (NYSE:OGN) Just Reported Its Third-Quarter Results And Analysts Are Updating Their ForecastsNovember 6, 2024 | finance.yahoo.comOrganon & Co. (NYSE:OGN) Sees Unusually-High Trading Volume - Here's WhyOrganon & Co. (NYSE:OGN) Sees Unusually-High Trading Volume - Here's WhyNovember 5, 2024 | marketbeat.comOrganon & Co. (NYSE:OGN) Stock Price Down 4.4% - Here's What HappenedOrganon & Co. (NYSE:OGN) Trading Down 4.4% - Here's What HappenedNovember 4, 2024 | marketbeat.comPrivate Management Group Inc. Acquires 34,026 Shares of Organon & Co. (NYSE:OGN)Private Management Group Inc. boosted its holdings in Organon & Co. (NYSE:OGN - Free Report) by 1.8% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,893,868 shares of the company's stock after purchasing an aNovember 2, 2024 | marketbeat.comOrganon Q3 2024 Earnings Preview: Dermavant purchase in focusNovember 1, 2024 | seekingalpha.comEvercore ISI Sticks to Its Buy Rating for Organon (OGN)November 1, 2024 | markets.businessinsider.comOrganon & Co. (NYSE:OGN) to Issue $0.28 Quarterly DividendOrganon & Co. (NYSE:OGN) declared a quarterly dividend on Thursday, October 31st. Investors of record on Tuesday, November 12th will be paid a dividend of 0.28 per share on Thursday, December 12th. This represents a $1.12 dividend on an annualized basis and a yield of 5.96%. The ex-dividend date is Tuesday, November 12th.November 1, 2024 | marketbeat.comOrganon & Co. (OGN) Q3 2024 Earnings Call TranscriptNovember 1, 2024 | seekingalpha.comOrganon & Co. Reports Strong Third Quarter 2024 ResultsNovember 1, 2024 | markets.businessinsider.comOrganon & Co. 2024 Q3 - Results - Earnings Call PresentationOctober 31, 2024 | seekingalpha.comOrganon & Co. (NYSE:OGN) Short Interest Up 28.2% in OctoberOrganon & Co. (NYSE:OGN - Get Free Report) saw a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 12,530,000 shares, an increase of 28.2% from the September 30th total of 9,770,000 shares. Based on an average trading volume of 1,920,000 shares, the short-interest ratio is currently 6.5 days. Approximately 4.9% of the company's stock are sold short.October 28, 2024 | marketbeat.comOrganon & Co trades in the red for seven straight sessionsOctober 24, 2024 | seekingalpha.comWant $300 in Dividends Every Month? Invest $20,000 in Each of These 3 StocksOctober 24, 2024 | fool.comOrganon & Co. (OGN) Set to Announce Earnings on ThursdayOrganon & Co. (NYSE:OGN) will be releasing earnings before the market opens on Thursday, October 31, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634270)October 24, 2024 | marketbeat.comExchange Traded Concepts LLC Increases Stake in Organon & Co. (NYSE:OGN)Exchange Traded Concepts LLC grew its position in Organon & Co. (NYSE:OGN - Free Report) by 230.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 162,607 shares of the company's stock afOctober 15, 2024 | marketbeat.comWedge Capital Management L L P NC Has $28.26 Million Stock Position in Organon & Co. (NYSE:OGN)Wedge Capital Management L L P NC cut its holdings in Organon & Co. (NYSE:OGN - Free Report) by 8.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,477,258 shares of the company's stock after selling 144,619 shares during the periodOctober 14, 2024 | marketbeat.comSound Income Strategies LLC Purchases 39,173 Shares of Organon & Co. (NYSE:OGN)Sound Income Strategies LLC raised its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 6.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 611,380 shares of the company's stock afteOctober 13, 2024 | marketbeat.comOrganon & Co. (NYSE:OGN) Shares Sold by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company trimmed its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 58.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 59,553 shares of thOctober 12, 2024 | marketbeat.comOrganon (OGN) Gets a Hold from Morgan StanleyOctober 11, 2024 | markets.businessinsider.comSquarepoint Ops LLC Invests $671,000 in Organon & Co. (NYSE:OGN)Squarepoint Ops LLC acquired a new stake in Organon & Co. (NYSE:OGN - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 32,408 shares of the company's stock, valued at approximately $671,000. A number of otherOctober 9, 2024 | marketbeat.comForesight Capital Management Advisors Inc. Invests $1.01 Million in Organon & Co. (NYSE:OGN)Foresight Capital Management Advisors Inc. acquired a new stake in shares of Organon & Co. (NYSE:OGN - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 52,949 shares of the company's stock, vOctober 7, 2024 | marketbeat.comSanctuary Advisors LLC Takes $5.56 Million Position in Organon & Co. (NYSE:OGN)Sanctuary Advisors LLC purchased a new position in shares of Organon & Co. (NYSE:OGN - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 268,590 shares of the company's stock, valued at approximately $5,560,000. Sanctuary Advisors LOctober 5, 2024 | marketbeat.comEU regulator reviews anti-baldness drugs over concerns of suicidal thoughtsOctober 4, 2024 | reuters.comEU regulators reviewing safety of finasteride, dutasterideOctober 4, 2024 | seekingalpha.comHsbc Holdings PLC Has $263,000 Holdings in Organon & Co. (NYSE:OGN)Hsbc Holdings PLC decreased its stake in shares of Organon & Co. (NYSE:OGN - Free Report) by 78.9% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 12,700 shares of the company's stock after selling 47,463 shares duOctober 4, 2024 | marketbeat.comOrganon & Co. (NYSE:OGN) Shares Sold by Algert Global LLCAlgert Global LLC trimmed its stake in Organon & Co. (NYSE:OGN - Free Report) by 24.6% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 176,553 shares of the company's stock after selling 57,743 shares during the quarter. AOctober 1, 2024 | marketbeat.comDimensional Fund Advisors LP Increases Position in Organon & Co. (NYSE:OGN)Dimensional Fund Advisors LP increased its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 23.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,407,915 shares of theSeptember 30, 2024 | marketbeat.comOrganon & Co. (NYSE:OGN) Shares Purchased by Susquehanna Fundamental Investments LLCSusquehanna Fundamental Investments LLC grew its holdings in shares of Organon & Co. (NYSE:OGN - Free Report) by 28.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 429,370 shares of the company's stoSeptember 29, 2024 | marketbeat.comLighthouse Investment Partners LLC Invests $4.97 Million in Organon & Co. (NYSE:OGN)Lighthouse Investment Partners LLC acquired a new position in shares of Organon & Co. (NYSE:OGN - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 240,000 shares of the company's stock, valued atSeptember 28, 2024 | marketbeat.comOrganon Canada and the Alberta Women's Health Foundation unite to raise awareness and advocate for universal access to contraception in CanadaSeptember 27, 2024 | theglobeandmail.comDeprince Race & Zollo Inc. Grows Stake in Organon & Co. (NYSE:OGN)Deprince Race & Zollo Inc. raised its holdings in Organon & Co. (NYSE:OGN - Free Report) by 6.8% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,421,703 shares of the company's stock after acquiring an additional 216,907 shSeptember 26, 2024 | marketbeat.comAre Options Traders Betting on a Big Move in Organon (OGN) Stock?September 25, 2024 | finance.yahoo.comPublic Sector Pension Investment Board Increases Holdings in Organon & Co. (NYSE:OGN)Public Sector Pension Investment Board lifted its position in Organon & Co. (NYSE:OGN - Free Report) by 8.0% in the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 565,866 shares of the company's stock after purchasing an additional 41,954 shares during theSeptember 24, 2024 | marketbeat.comMagnetar Financial LLC Has $18.69 Million Stake in Organon & Co. (NYSE:OGN)Magnetar Financial LLC cut its position in shares of Organon & Co. (NYSE:OGN - Free Report) by 66.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 902,825 shares of the company's stock after selling 1,82September 23, 2024 | marketbeat.comOrganon: A Surprising DealSeptember 22, 2024 | seekingalpha.comOrganon & Co. (NYSE:OGN) Shares Sold by Sound Shore Management Inc. CTSound Shore Management Inc. CT reduced its stake in Organon & Co. (NYSE:OGN - Free Report) by 3.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,870,683 shares of the company's stoSeptember 21, 2024 | marketbeat.comAssessing Organon’s Strategic Acquisition of Dermavant: A Balanced Hold Recommendation Amid Growth and ChallengesSeptember 19, 2024 | markets.businessinsider.comRoivant's Sale Of Dermavant To Organon: A Strategic Win-Win In Atopic DermatitisSeptember 19, 2024 | seekingalpha.comEvercore ISI Sticks to Their Buy Rating for Organon (OGN)September 19, 2024 | markets.businessinsider.com Get Organon & Co. News Delivered to You Automatically Sign up to receive the latest news and ratings for OGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too? Click Here For Your Free Guide OGN Media Mentions By Week OGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OGN News Sentiment▼1.050.55▲Average Medical News Sentiment OGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OGN Articles This Week▼75▲OGN Articles Average Week Get Organon & Co. News Delivered to You Automatically Sign up to receive the latest news and ratings for OGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VTRS News SMMT News GMAB News PCVX News RDY News SRPT News CTLT News RVMD News QGEN News ITCI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:OGN) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organon & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organon & Co. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
